Tysabri (natalizumab)

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)

Published: 5 Feb-2005

DOI: 10.3833/pdr.v2005.i56.719     ISSN: 1756-7874

Section: Deal Trackers



Tysabri belongs to a new class of humanised monoclonal antibody, known as selective adhesion molecule (SAM) inhibitors, that block α4β1-integrin mediated leucocyte migration into infl amed tissue...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details